Literature DB >> 15290863

Significant role of liver sinusoidal endothelial cells in hepatic uptake and degradation of naked plasmid DNA after intravenous injection.

Jin Hisazumi1, Naoki Kobayashi, Makiya Nishikawa, Yoshinobu Takakura.   

Abstract

PURPOSE: Uptake and degradation of naked plasmid DNA (pDNA) by liver sinusoidal endothelial cells (LSECs) were investigated.
METHODS: Tissue distribution and intrahepatic localization were determined after an intravenous injection of 111In- or 32P-labeled pDNA into rats. Cellular uptake and degradation of fluorescein- or 32P-labeled pDNA were evaluated using primary cultures of rat LSECs.
RESULTS: Following intravenous injection, pDNA was rapidly eliminated from the circulation and taken up by the liver. Fractionation of liver-constituting cells by centrifugal elutriation revealed a major contribution of LSECs to the overall hepatic uptake of pDNA. Confocal microscopic study confirmed intracellular uptake of pDNA in cultured LSECs. Apparent cellular association of pDNA was similar at 37 degrees C and 4 degrees C. However, trichloroacetic acid (TCA) precipitation experiments showed the TCA-soluble radioactivity in the culture medium increased in an accumulative manner at 37 degrees C. Involvement of a specific mechanism was demonstrated, as the uptake of pDNA was significantly inhibited by excess unlabeled pDNA and some polyanions (polyinosinic acid, dextran sulfate, heparin) but not by others (polycytidylic acid, dextran). These inhibitors also reduced the amount of TCA-soluble radioactivity in the culture medium. CONCLUSION. These results suggest that LSECs efficiently ingested and rapidly degraded naked pDNA in vivo and in vitro and released the degradation products into the extracellular space.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290863     DOI: 10.1023/b:pham.0000033009.17594.e5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

Review 1.  Local control of the immune response in the liver.

Authors:  P A Knolle; G Gerken
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

Review 2.  Hepatic and extrahepatic scavenger receptors: function in relation to disease.

Authors:  V Terpstra; E S van Amersfoort; A G van Velzen; J Kuiper; T J van Berkel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

Review 3.  Anti-DNA and autoantibodies.

Authors:  D S Pisetsky
Journal:  Curr Opin Rheumatol       Date:  2000-09       Impact factor: 5.006

4.  Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures.

Authors:  N Kobayashi; T Kuramoto; K Yamaoka; M Hashida; Y Takakura
Journal:  J Pharmacol Exp Ther       Date:  2001-06       Impact factor: 4.030

5.  Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells.

Authors:  W Emlen; A Rifai; D Magilavy; M Mannik
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

6.  Clearance and organ localization of small DNA anti-DNA immune complexes in mice.

Authors:  W Emlen; G Burdick
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

7.  Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells.

Authors:  S Magnússon; T Berg
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices.

Authors:  A M Pearson; A Rich; M Krieger
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

9.  Kinetics and mechanisms for removal of circulating single-stranded DNA in mice.

Authors:  W Emlen; M Mannik
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

10.  An electron microscope autoradiographic study of the carbohydrate recognition systems in rat liver. I. Distribution of 125I-ligands among the liver cell types.

Authors:  A L Hubbard; G Wilson; G Ashwell; H Stukenbrok
Journal:  J Cell Biol       Date:  1979-10       Impact factor: 10.539

View more
  7 in total

1.  Dysopsonin activity of serum DNA-binding proteins favorable for gene delivery.

Authors:  Feng Liu; Amber Frick; Xing Yuan; Leaf Huang
Journal:  J Pharmacol Exp Ther       Date:  2009-10-28       Impact factor: 4.030

2.  MGMT promoter methylation in serum and cerebrospinal fluid as a tumor-specific biomarker of glioma.

Authors:  Zheng Wang; Wei Jiang; Yahong Wang; Yang Guo; Zheng Cong; Fangfang DU; Bin Song
Journal:  Biomed Rep       Date:  2015-05-13

3.  Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery.

Authors:  Nicholas J Baumhover; Jason T Duskey; Sanjib Khargharia; Christopher W White; Samuel T Crowley; Rondine J Allen; Kevin G Rice
Journal:  Mol Pharm       Date:  2015-11-05       Impact factor: 4.939

4.  PEG-Peptide Inhibition of Scavenger Receptor Uptake of Nanoparticles by the Liver.

Authors:  Rondine J Allen; Basil Mathew; Kevin G Rice
Journal:  Mol Pharm       Date:  2018-08-13       Impact factor: 4.939

5.  Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades.

Authors:  Iris Lavon; Miri Refael; Bracha Zelikovitch; Edna Shalom; Tali Siegal
Journal:  Neuro Oncol       Date:  2010-02-01       Impact factor: 12.300

6.  Protocol for Isolation and Culture of Mouse Hepatocytes (HCs), Kupffer Cells (KCs), and Liver Sinusoidal Endothelial Cells (LSECs) in Analyses of Hepatic Drug Distribution.

Authors:  Kjetil Elvevold; Ingelin Kyrrestad; Bård Smedsrød
Journal:  Methods Mol Biol       Date:  2022

7.  α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice.

Authors:  Julen Rodríguez-Castejón; Ana Alarcia-Lacalle; Itziar Gómez-Aguado; Mónica Vicente-Pascual; María Ángeles Solinís Aspiazu; Ana Del Pozo-Rodríguez; Alicia Rodríguez-Gascón
Journal:  Pharmaceutics       Date:  2021-05-21       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.